Characterization of a Protease-resistant Domain of the Cytosolic Portion of Sarcoplasmic Reticulum Ca2+-ATPase
NUCLEOTIDE- AND METAL-BINDING SITES*

Philippe ChampeilDagger §, Thierry MenguyDagger , Stéphanie SouliéDagger , Birte Juulpar , Adrienne Gomez de GraciaDagger , Filippo Rusconi**Dagger Dagger , Pierre FalsonDagger , Luc Denoroy§§¶¶, Fernando Henao||, Marc le MaireDagger §, and Jesper Vuust Møllerpar

From the Dagger  URA 2096 (CNRS) and Section de Biophysique des Protéines et des Membranes, Département de Biologie Cellulaire et Moléculaire, CEA Saclay, 91191 Gif-sur-Yvette Cedex, ** Laboratoire de Neurobiologie et Diversité Cellulaire, CNRS (URA 2054) and Ecole Supérieure de Physique et Chimie Industrielles de la Ville de Paris, 10 rue Vauquelin, 75231 Paris Cedex 05, ¶¶ Service Central d'Analyse (CNRS), BP 22, 69390 Vernaison, France, || Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias, Universidad de Extremadura, 06080 Badajoz, Spain, and par  Department of Biophysics, University of Aarhus, Ole Worms Allé 185, 8000 Aarhus C, Denmark

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Treatment of rabbit sarcoplasmic reticulum Ca2+-ATPase with a variety of proteases, including elastase, proteinase K, and endoproteinases Asp-N and Glu-C, results in accumulation of soluble fragments starting close to the ATPase phosphorylation site Asp351 and ending in the Lys605-Arg615 region, well before the conserved sequences generally described as constituting the "hinge" region of this P-type ATPase (residues 670-760). These fragments, designated as p29/30, presumably originate from a relatively compact domain of the cytoplasmic head of the ATPase. They retain two structural characteristics of intact Ca2+-ATPase as follows: high sensitivity of peptidic bond Arg505-Ala506 to trypsin cleavage, and high reactivity of lysine residue Lys515 toward the fluorescent label fluorescein 5'-isothiocyanate. Regarding functional properties, these fragments retain the ability to bind nucleotides, although with reduced affinity compared with intact Ca2+-ATPase. The fragments also bind Nd3+ ions, leaving open the possibility that these fragments could contain the metal-binding site(s) responsible for the inhibitory effect of lanthanide ions on ATPase activity. The p29/30 soluble domain, like similar proteolytic fragments that can be obtained from other P-type ATPases, may be useful for obtaining three-dimensional structural information on the cytosolic portion of these ATPases, with or without bound nucleotides. From our findings we infer that a real hinge region with conformational flexibility is located at the C-terminal boundary of p29/30 (rather than in the conserved region of residues 670-760); we also propose that the ATP-binding cleft is mainly located within the p29/30 domain, with the phosphorylation site strategically located at the N-terminal border of this domain.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The detailed structure of membrane proteins is only known in a few cases. Among P-type ATPases, which are responsible for active cation transport, the best structure to date is only known to about 14 Å resolution, from cryo-electron microscopy; this is for Ca2+-ATPase, which catalyzes uptake of Ca2+ from the cytosol to the endoplasmic or sarcoplasmic Ca2+-storing compartment (1-3). However, large three-dimensional crystals of the protein are not available as yet, and the ATPase structure has been mainly deduced from electron microscopy studies of two-dimensional crystals (3-6), combined with studies by other techniques like chemical labeling, Förster-type resonance energy transfer, immunoreactivity of antibodies with various epitopes, site-directed mutagenesis, and proteolysis studies (reviewed in Refs. 7-9). By comparing structures of Ca2+-ATPase with and without bound nucleotide, suggestions have been made concerning the likely location of the ATP-binding site in the cytoplasmic portion of this pump (10), but the actual structure of the ATP-binding site and the mechanism of ATP hydrolysis are still largely unknown. Nevertheless, it has been hypothesized that this region of the Ca2+-ATPase might be organized like water-soluble phosphokinases, with a hinge transiently bringing an ATP-binding and a phosphate-accepting region in close apposition during the ATPase enzymatic cycle (Ref. 11 and reviewed in Refs. 8 and 12).

As a first step toward determining the structure of the entire ATPase, it would be useful to determine the structure of smaller fragments, provided that such fragments reflect the structure of the corresponding region in the intact protein. A few studies have paved the way in this direction, by trying to express in bacterial systems soluble fragments of ATPase with anticipated autonomous functional properties (13, 14). Proteolysis experiments can contribute to the success of such studies, since protease-resistant fragments probably constitute domains whose structural properties can be investigated with minimal risk of instability. Following our previous analysis of Ca2+-ATPase proteolysis by proteinase K (15), we now report on the properties of closely related proteolytic fragments with molecular masses of 29/30 kDa, derived from the large cytosolic loop, which we show retain many of the properties of the corresponding region in intact Ca2+-ATPase. In view of the stability and functional properties of these fragments, we suggest that such a soluble 30-kDa fragment of Ca2+-ATPase could be a reasonable candidate for future three-dimensional structure determination. From our results we also infer possible implications for the organization of the cytosolic portion of P-type ATPases.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Most of the methods used in this report have been described in detail previously, including the isolation of SR1 vesicles (16) and their FITC labeling (17), preparation of purified ATPase by deoxycholate extraction (18), proteolysis and analysis of the resultant peptides (15, 19, 20), handling of lanthanide ions (21), and general fluorescence methods, including the use of TNP-nucleotides (22). Fluorescence recordings were obtained with a SPEX fluorolog instrument; SDS-PAGE gels were digitized with a Bio-Rad camera and Molecular Analyst software. Total amino acid analysis after acid hydrolysis of the peptides was performed by F. Baleux, Unité de Chimie Organique, Département de Biochimie et Génétique Moléculaire at Institut Pasteur, Paris. CD Spectra were run on a Jobin-Yvon CD6 spectrodichrograph and were analyzed with the Dichroprot software.2

Mass Spectrometry-- In this work, mass spectrometry was not performed after ElectroSpray Ionization (as in our previous work, see Ref. 15), but we used the matrix-assisted laser desorption ionization-time of flight technique (23). MALDI-TOF spectra of proteolytic peptides were obtained with a Voyager-Elite Biospectrometry Workstation mass spectrometer (PerSeptive Biosystems Inc., Framingham, MA). Each sample was first desalted and then loaded on the target by the dried droplet method; the matrix was 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid, Aldrich). Spectra were calibrated externally with a two-point calibration using the [M + H+] and the [M + 2H+] ions from a protein standard, horse apomyoglobin (m/z = 16952.5 and 8476.8, respectively). The analysis was performed in the positive and linear modes, with an accelerating voltage of 25,000 V. Different extraction delays were used (150, 275, or 400 ns), and around 120 scans were averaged. Typically, the amount of peptide analyzed was 5-10 pmol.

MALDI-TOF spectra were run to determine the C termini of the soluble fragments produced by proteolysis (see Fig. 1) with various proteolytic enzymes. After proteolysis, samples were processed in one of two ways. In the case of Asp-N, the supernatant of Asp-N-treated SR was simply desalted by passing through a Sephadex G25M column equilibrated with a 10 mM ammonium bicarbonate buffer at pH 8.1 and examined directly by mass spectrometry. Since the N terminus of the 30-kDa proteolytic peptide was already known from N-terminal sequencing, determination of its total mass by MALDI-TOF (to within 10 Da) allowed us to determine its C-terminal residue without ambiguity. In the case of elastase and proteinase K, which are proteolytic enzymes with relatively poor specificity (and also after use of Asp-N, for control), the peptides found in the supernatants of treated SR were further cleaved with trypsin (as shown for proteinase K in Fig. 5), and the smaller peptides generated in this way were then desalted by binding to a C18 reversed phase resin (Sep-Pak, Waters Corp., Milford, MA) and elution with 80% acetonitrile and 0.1% trifluoroacetic acid (v/v) in deionized water (24). In this case, mass spectrometry revealed two groups of peaks (see Fig. 6) in the 16-17-kDa range and in the 11-12-kDa range, respectively, corresponding to the N-terminal and C-terminal parts of the original peptides, respectively, and confirmed that these peptides had been cut by trypsin at a single site, Arg505-Ala506 (as shown for proteinase K in detail, see "Results"). The masses measured for the 16-17-kDa peptides confirmed the results of the previous N-terminal sequencing experiments. The masses measured for the 11-12-kDa peptides, which corresponded to peptides starting at the trypsin cleavage site (Arg505-Ala506) and ending at the C termini of the original peptides, allowed to identify the latter unambiguously in all cases (again to within 10 Da).

Binding of [gamma -32P]ATP to Soluble Fragments, as Deduced from Ultrafiltration Experiments-- To measure directly equilibrium binding of ATP to the soluble p29/30 fragments resulting from Ca2+-ATPase proteolysis, we took advantage of the ability of appropriate ultrafiltration membranes (Centricon 10 devices, Amicon) to concentrate these soluble peptides while allowing free passage of ATP. Samples for ultrafiltration (2 ml) were transferred to Centricon 10 tubes and centrifuged for 150 min at 5000 rpm in a Beckman JA-12 rotor. After centrifugation, the various samples were concentrated to about the same extent (about 30-fold), as indicated by measurements of protein concentrations. Protein-bound ATP versus free ATP was determined from the excess ATP in the concentrated sample over that present in the ultrafiltrate, after correction for the small "blank" value (a few %) found in experiments performed with protein-free samples. Control measurements with intact SR vesicles were included. Experiments were performed on samples containing various concentrations of ATP, to which a constant concentration of [gamma -32P]ATP tracer was added, to measure competition between nonlabeled and labeled ligand (e.g. Ref. 65). [3H]Glucose was also added as an inert tracer, and the concentrations of ATP were deduced from the ratios of 32P and 3H counts. The data were analyzed in terms of Michaelian binding, according to Equation 1.
[<UP>EL</UP>]/[<UP>L</UP>]={[<UP>E<SUB>tot</SUB></UP>]/(K<SUB>d</SUB>+[<UP>L</UP>])}+&agr; (Eq. 1)
where [EL] and [L] are the concentrations of bound and free ligand (ATP), respectively; [Etot] and Kd are the concentration of binding sites and the binding affinity, and alpha  corresponds to a small fraction of nonspecific binding. Plotting the fraction of ATP bound (i.e. [EL]/[L]) as a function of free ATP ([L]), as in Fig. 4, thus permits us to directly estimate Kd from the concentration of free ATP for which this fraction is reduced to half of its maximal value, obtained at low ligand concentration; in turn, this maximal value, which is equal to {[Etot]/Kd} alpha , permits estimation of the concentration of the ATP-binding sites in the sample (Etot). A full description of the method will be given elsewhere.3

In the case of p29/30 peptides, a special problem arises because these peptides are prepared as the high speed supernatant of protease-treated SR membranes; in such a protocol, a small fraction (possibly a few percent) of the original membranes may escape pelleting, and these non-pelleted membranes may contain a small fraction of either residual intact ATPase or only partially cleaved ATPase (e.g. the membranous p83C peptide, which is able to bind ATP and be phosphorylated, see Ref. 15). Unfortunately, for estimation of a binding affinity, contamination of a sample (with an anticipated relatively poor affinity for its ligand) by a component of higher affinity is a real complication (e.g. see Ref. 66). To eliminate such contamination, we submitted the p29/30-containing supernatant to a preliminary step of centrifugation on an ultrafiltration membrane with a 100,000-dalton cut-off (2-ml samples were loaded onto Centricon 100 devices and centrifuged for 135 min at 2400 rpm in a Beckman JA-12 rotor); SDS-PAGE showed that contaminating SR membranes were retained by the Centricon membrane but that p29/30 peptides were recovered in the filtrate. These peptides were subsequently used for the ultrafiltration experiments with Centricon 10.

Metal-binding Properties of Bis-Tris Buffer-- In some cases, for treatment of SR vesicles with proteinase K at pH 6.5, we replaced the Bis-Tris buffer of our original standard medium (15) by a Mops/NaOH buffer at the same pH. This is because we found that Bis-Tris buffer (but not Mops/NaOH buffer) binds Ca2+ with an apparent dissociation constant around 25 mM at this pH, so that in the presence of 100 mM Bis-Tris and a certain amount of total Ca2+, the free [Ca2+] is about 5-fold lower than the total [Ca2+]. Although this has no implication for the present results, it explains why, in our previous work (15), unexpectedly high concentrations of Ca2+ were required to protect the ATPase transmembrane bundle from denaturation during proteinase K treatment.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Protease-resistant Soluble Fragments of Ca2+-ATPase-- The starting point for the present work was the observation that treatment of sarcoplasmic reticulum Ca2+-ATPase with a variety of proteases generally leads to accumulation of soluble fragments of about 30 kDa, which are relatively resistant to further proteolysis. Fig. 1 shows an experiment in which SR vesicles were treated with elastase (El, left), proteinase K (prK, central lanes), or Asp-N (AspN, right). Aliquots of the treated samples were centrifuged, and peptides found in either the total sample (Tot), the pellet (Pel), or the supernatant (Sup) were separated by SDS-PAGE. In all three cases, irrespective of the proteolytic enzyme, the supernatant (lanes 4, 8, and 12) contains, in addition to the protease itself (asterisk), one or two major proteolytic fragment(s) of about 30 kDa (see arrows). In the case of Asp-N, a faint band at the position of intact ATPase also shows up in the supernatant, but this is presumably due to contamination of the protease with phospholipase. Treatment of SR vesicles with endoproteinase Glu-C protease also results in appearance of a 31-kDa fragment (not shown).


View larger version (76K):
[in this window]
[in a new window]
 
Fig. 1.   Accumulation of soluble fragments of Ca2+-ATPase in the 29-30-kDa range after proteolysis by various proteases. SDS-PAGE (using a 12.5% acrylamide Laemmli gel prepared in the absence of Ca2+) was used to separate the peptides present in various protein samples. Lane 14, molecular mass standards (low molecular weight standards) (LMW). Lane 1, control intact SR vesicles (SR); the ATPase is indicated, as well as calsequestrin (Cals) and M55, two extrinsic proteins. Lanes 2-4, SR vesicles (at a final concentration of 1 mg/ml) were incubated for 30 min with 30 µg/ml pancreatic elastase (El), in a medium containing 100 mM Bis-Tris and 1 mM EGTA at pH 6.5 and 22 °C, and the reaction was stopped with 0.5 mM diisopropyl fluorophosphate; 100-µl samples were then centrifuged (Beckman rotor TLA 100, 75,000 rpm, about 200,000 gav, for 60 min), and aliquots of total sample (Tot), resuspended pellet (Pel), and supernatant (Sup) were loaded onto the gel. Lane 5, elastase alone (El, asterisk). Lanes 6-8, same experiment, except that SR vesicles were now incubated for 30 min with 30 µg/ml proteinase K (prK), in a medium containing 100 mM Bis-Tris and 0.3 mM Ca2+ at pH 6.5 and 20 °C, and the reaction was stopped with 0.5 mM PMSF. Lane 9, proteinase K alone (prK, asterisk). Lanes 10-12, same experiment, except that SR vesicles were incubated with Asp-N (AspN), instead of proteinase K, and stopped with 1 mM EDTA; in this case, proteolysis was performed with only 3 µg/ml Asp-N, allowing for limited proteolysis but also limited ATPase solubilization by the contaminating phospholipase. Lane 13, Asp-N alone; Asp-N is hardly visible but can be detected at the location indicated by the asterisk. The various arrows point to the soluble proteolytic fragments.

The fragments found in the supernatants were identified as peptides originating from the large cytosolic domain of Ca2+-ATPase by immunoblotting with sequence-specific antibodies and N-terminal sequencing (15); mass spectrometry experiments (some of which will be described below in Fig. 6; see "Experimental Procedures") were also performed for identification of C termini. The conclusion from all these experiments regarding the identification of the soluble peptide fragments is shown in Table I. It appears that the region surrounding the Arg505-Ala506 peptidic bond, known to be highly reactive to trypsin, is not a major target for the other proteases. Cleavage by Asp-N is found to occur at locations just N-terminal of an aspartic residue (Ser350-Asp351 and Arg615-Asp616 bonds), and cleavage by endoproteinase Glu-C occurs after glutamic acid residues (e.g. at Glu340-Thr341), as expected. Cleavage by proteinase K does not appear to be particularly specific of certain amino acid residues (see also Ref. 15) but occurs at a few sites only, presumably because of the local peptide conformation. This also seems to apply to elastase. A remarkable finding is that all fragments more or less coincide, as they all start close to the ATPase phosphorylation site, Asp351, and end close to Ser610, in the Lys605-Arg615 region. This suggests the existence, between Asp351 and Ser610, of a region of relatively compact structure resistant to proteolysis, characteristic of a structural domain in the cytoplasmic portion of the ATPase. In the following sections, we mainly used peptides derived from proteinase K-treated SR vesicles (a mixture of "p29" and "p30" peptides, starting at Thr357 and Ser350, respectively, and ending after either Met608 or Ser610), to ask to what extent the isolated peptides retain properties resembling those of the polypeptide chain in the native structure. To do this, we studied nucleotide- and metal-binding properties of p29/30 fragments as well as their sensitivity to trypsin and reactivity toward FITC, and we characterized the secondary structure of these fragments as well as their hydrodynamic and spectroscopic properties.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Identification of protease-resistant fragments of Ca2+-ATPase

Retention of Nucleotide- and TNP-nucleotide-binding Properties for p29/30 Fragments, as Deduced from TNP-nucleotide Fluorescence-- To study the nucleotide-binding properties of these soluble Ca2+-ATPase fragments, we took advantage of the fact that the fluorescence of a TNP-nucleotide is 3- or 4-fold higher when it is bound to Ca2+-ATPase than when it is free in solution (14, 25, 26). This is shown in panel A of Fig. 2, which shows control experiments with TNP-ATP and intact SR. Using excitation and emission wavelengths optimal for detection of TNP-ATP fluorescence (410 and 540 nm, respectively), addition of TNP-ATP to an SR-containing cuvette results in an increase in the intensity of the signal which is almost completely reversed when TNP-ATP is chased off the nucleotide-binding sites by subsequent addition of a high concentration of ATP. The difference between the residual signal intensity in the presence of both ATP and TNP-ATP and the signal intensity in the absence of both nucleotides corresponds to the fluorescence of free TNP-ATP. This can be seen in experiments in which TNP-ATP is added to an SR-free sample; in this case (see panel B experiment, in which the supernatant of a centrifuged SR suspension provides such a sample), the base-line signal before TNP-ATP addition is very low (because this signal is directly related to the amount of light scattered by the sample) and the small TNP-ATP-dependent signal is not altered upon ATP addition. Thus, the large TNP-ATP-dependent signal observed in the presence of SR vesicles, partially reversed by ATP, reveals TNP-ATP binding to the ATPase nucleotide site.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 2.   Nucleotide binding to p29/30 fragments, as deduced from TNP-ATP fluorescence measurements. To detect TNP-ATP fluorescence (panels A-D), the excitation wavelength was set at 410 nm (bw = 5 nm), and the emission wavelength was set at 540 nm (bw = 20 nm). Experiments were performed with control SR vesicles (panels A and B) or proteinase K-treated vesicles (panels C and D). SR vesicles at 1 mg/ml were incubated for 30 min at 20 °C in the absence (A and B) or presence (C and D) of 30 µg/ml proteinase K, in a medium containing 100 mM Mops-NaOH and 0.3 mM Ca2+ at pH 6.5; the reaction was stopped by addition of 0.5 mM PMSF; 1.5-ml aliquots of the samples were centrifuged (Beckman 50 Ti rotor at 40,000 rpm, about 125,000 gav, for 80 min), and supernatants (Sup, B and D) as well as total non-centrifuged samples (Tot, A and C) were examined. In the fluorescence cuvette, 0.5-ml samples were mixed with 0.5 ml of 200 mM KCl, 2 mM EDTA, and 30 mM Tris-HCl at pH 9; the final suspension pH was 7. Then, 5 µM TNP-ATP was added (17 µl of a 300 µM stock solution), followed by several additions of 6 mM ATP (60 µl of 100 mM ATP each time). Finally, sample aliquots were analyzed by SDS-PAGE (panel E on the right).

Panels C and D in Fig. 2 show the outcome of corresponding experiments performed on proteinase K-treated SR vesicles. With both total sample (panel C) and supernatant (panel D), ATP is still effective in reducing the signal observed in the presence of TNP-ATP, suggesting ATP-displaceable TNP-ATP binding to isolated p29/30 fragments. SDS-PAGE analysis of the various samples used in this experiment is shown on the right of Fig. 2, confirming degradation of Ca2+-ATPase and formation of appreciable amounts of p29/30 after proteinase K treatment, as in Fig. 1. In complementary experiments, we found that both the TNP-ATP-dependent signal in the supernatant of proteinase K-treated samples and the magnitude of the ATP-induced drop in this signal (as in panel D) depend on the duration of the proteolysis period; they rise to a maximal value after about 30 min of proteolysis at pH 6.5 and subsequently decline, in close agreement with the amount of p29/30 fragments which can be estimated from SDS-PAGE gels (data not shown). In Fig. 2, the fact that changes in TNP-ATP fluorescence are smaller upon binding to non-centrifuged but proteinase K-treated ATPase (panel C) than upon binding to intact Ca2+-ATPase (panel A) is probably due to a combination of factors, such as proteolysis-induced modification of the environment of TNP-ATP in its site (resulting in reduced fluorescence enhancement upon binding), lower affinity of TNP-ATP for p29/30 than for Ca2+-ATPase (see below), and slow conversion of p29/30 to smaller fragments (which no longer bind TNP-ATP). On the other hand, the fact that changes in TNP-ATP fluorescence are smaller upon binding to the supernatant of treated ATPase (panel D) than upon binding to non-centrifuged samples (panel C) is probably due in part to the fact that the membranous fraction still contains a few ATPase chains either completely intact or only partially cleaved by proteinase K, such as the membranous 83-kDa peptide which retains full reactivity toward ATP (15). In addition, p29/30 fragments may weakly bind to portions of the ATPase still attached to the membrane and be partially pelleted together with the membrane fraction (see lane 7 in Fig. 1).

Retention of Nucleotide and TNP-nucleotide-binding Properties for p29/30 Fragments, as Deduced from Intrinsic Fluorescence Measurements-- In p29/30 fragments, one Trp residue, Trp552 (out of a total of 13 Trp residues in intact Ca2+-ATPase) is present. Thus, it is also possible to study nucleotide binding to p29/30 by monitoring changes in intrinsic (Trp) fluorescence. TNP-ATP is known to quench Ca2+-ATPase intrinsic fluorescence, both by a saturable mechanism due to Förster transfer from Trp552 to the TNP moiety of bound TNP-ATP (Ref. 27; R0 = 24 Å, see Ref. 22) and by a non-saturable quenching due to light absorption by the added nucleotide (an "inner filter" effect). These effects can be seen in panel A of Fig. 3, which illustrates a control experiment with intact Ca2+-ATPase and TNP-ATP; in this case, there is a well defined break in the quenching curve (27), indicating high affinity binding of the TNP-nucleotide. When the experiment is repeated with p29/30 peptides (panel B of Fig. 3), there is also evidence for a saturable component in the quenching curve but with lower affinity (the apparent dissociation constant is a few µM for p29/30 peptides, compared with much less than 1 µM for intact SR, see also Refs. 14 and 25). The same result is obtained when TNP-ADP is added, instead of TNP-ATP (see below). Interpretation of saturable quenching in terms of binding to the nucleotide site is strengthened by the demonstration that this quenching is reversed when the TNP-nucleotide is chased off its binding site by addition of nucleotide. This is shown in panels C and D of Fig. 3, in which ADP was added to samples pretreated with TNP-ADP; both for control ATPase (panel C) and for p29/30 fragments (panel D), a high concentration of ADP does reverse the quenching resulting from previous addition of TNP-ADP. This reversal is partial, because although Förster quenching is reversed, the reduction in signal intensity due to inner filter and dilution effects is of course not reversed, and added ADP further contributes to the latter effects. Note that this experiment started with addition of EDTA (ED), which, by chelating contaminating Ca2+, had a clear effect on the fluorescence of intact Ca2+-ATPase, as expected (28), but did not affect the fluorescence of p29/30 fragments, since these fragments are no longer connected to the ATPase transmembrane domain responsible for Ca2+ sensitivity (29).


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 3.   Binding of nucleotides to p29/30 fragments, as deduced from Trp fluorescence measurements. Experiments were performed either (i) with the supernatant of proteinase K-treated vesicles (prK Sup, panels B and D; here, SR vesicles at 2 mg of protein/ml were treated for 30 min with 30 µg/ml proteinase K in a medium containing 300 mM sucrose, 1 mM Mg2+, 0.01 mM Ca2+, and 10 mM Tricine-Tris, at pH 8 and 20 °C, and 3-ml aliquots were centrifuged with a Beckman 45Ti rotor at 40,000 rpm, about 185,000 gav, for 90 min), or (ii) with control SR, incubated under the same conditions but in the absence of proteinase K (SR, panels A and C). SDS-PAGE analysis of the resulting peptides is shown in panel E on the right. Intrinsic fluorescence was detected with lambda ex = 300 nm (bw = 2 nm), to minimize absorption by nucleotides, and with lambda em = 330 nm (bw = 10 nm). The fluorescence level of p29/30 fragments was more than 10-fold lower than that of intact Ca2+-ATPase; the data were normalized, 100% corresponding to the fluorescence of each sample in the absence of Ca2+ and nucleotide. In all cases, 100-µl protein aliquots were added to 1.9 ml of a medium containing 100 mM KCl and 50 mM Mops-Tris at pH 7 and 20 °C. Panels A and B, concentration dependence of fluorescence quenching by TNP-ATP, in the additional presence of 0.5 mM EDTA. The ordinate scale is logarithmic; dashed lines represent the inner filter component of quenching. Panels C and D, 2 µl of EDTA 0.5 M was first added to the sample (ED) to chelate contaminating Ca2+ (and Mg2+ contributed by the proteolysis medium); then, four additions of TNP-ADP were made, followed by several additions of ADP itself; panel C, additions of 0.4 µl of 10 mM TNP-ADP followed by additions of 20 µl of 200 mM ADP; panel D, additions of 1 µl of 10 mM TNP-ADP followed by additions of 50 µl of 200 mM ADP. The dotted lines show the "true" fluorescence levels in the presence of nucleotide, taking dilution and inner filter effects into account.

These results were obtained with a supernatant of SR vesicles that had been treated with proteinase K in a pH 8 sucrose medium instead of the previous pH 6.5 medium (see legend to Fig. 3). In this case, the ratio of p29 and p30 peptides is more in favor of p29 than after proteolysis under the previous conditions (compare SDS-PAGE results in panel E of Fig. 3 with those in panel E of Fig. 2), but the outcome of the above Trp fluorescence experiments was the same when proteolysis was performed in the pH 6.5 medium instead of the pH 8 sucrose medium (not shown). Note also that similar results were obtained with supernatants of SR vesicles that had been treated with elastase (as in Fig. 1) instead of proteinase K (data not shown). All these results provide unambiguous evidence for binding of both TNP-nucleotides and nucleotides themselves to 29/30 peptides, with a reduced but significant affinity.

Binding of [gamma -32P]ATP to p29/30 Fragments, as Deduced from Ultrafiltration Experiments-- For intact SR, binding of ADP or ATP in the absence of TNP-nucleotide can also be directly detected as a rise in ATPase intrinsic fluorescence (e.g. Ref. 30). However, when, in similar experiments, 1 mM ATP aliquots were sequentially added to p29/30 fragments, the resulting rise in fluorescence level was small; despite our efforts to reduce inner filter artifacts due to nucleotide absorbance as much as possible by excitation of Trp residues at 300 nm, this rise could only, after the first addition of ATP, compensate for the dilution and inner filter-induced artifacts expected and indeed observed after subsequent ATP additions (data not shown). Evaluation with this method of the affinity of p29/30 fragments for ATP was therefore not possible.

Thus, to measure directly the equilibrium binding of [gamma -32P]ATP to the soluble p29/30 peptides, we designed a protocol based on the opportunity provided by ultrafiltration membranes (Centricon 10 devices, Amicon) to concentrate these soluble peptides but let free [gamma -32P]ATP flow through them; measurement of the amount of [gamma -32P]ATP in the concentrate then corresponds to the sum of free ligand (as can be measured in the filtrate) and bound ligand (see "Experimental Procedures"), and including various amounts of nonradioactive ATP together with a constant amount of radioactive ATP tracer makes it possible to evidence competition between nonradioactive and radioactive ligands (e.g. Ref. 65). These experiments were conducted in the absence of Mg2+, and for comparative reasons included measurements with intact SR vesicles. The results of the experiments with intact SR (circles in Fig. 4), in which the membranes were loaded onto the Centricon 10 device at an initial concentration of 0.16 mg of protein/ml and were concentrated to 4.8 mg/ml (on average), are consistent with a Kd for ATP binding of 34 µM and a concentration of ATP-binding sites of about 15.3 µM, hence 3.2 nmol/mg, values which are similar to those previously described after filtration experiments with intact SR under the same conditions (e.g. Ref. 30). Triangles in Fig. 4 show similar experiments performed with p29/30 peptides at a molar concentration about 9-fold higher than that of ATPase in the SR samples of the previous experiments (see legend to Fig. 4). In this case, the amount of [gamma -32P]ATP bound, at low total concentrations of ATP, was about twice lower and was displaced by higher concentrations of nonradioactive ATP, consistent with binding of [gamma -32P]ATP to p29/30 peptides with an affinity 20-fold lower than in intact SR ATPase (Kd = 680 µM, total number of sites 138 µM).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   Comparison of binding of [gamma -32P]ATP to p29/30 fragments and to SR ATPase, as measured in the absence of Mg2+. Ultrafiltration experiments were performed with either intact SR (initially at a concentration of 0.2 mg protein/ml; these experiments are illustrated by circles) or p29/30 fragments (obtained after 30 min proteolysis of SR vesicles at 2 mg protein/ml and centrifugation, essentially as described in the legend to Fig. 3 except that in addition, the supernatant was loaded onto a Centricon 100 device and the ultrafiltrate was collected, to eliminate contamination of soluble peptides by non-pelleted membranes; these experiments are illustrated by triangles). To 1.6-ml aliquots of these protein samples (in 300 mM sucrose, 1 mM Mg2+, 0.01 mM Ca2+, and 10 mM Tricine-Tris at pH 8 and 20 °C), we added 0.2 ml of a concentrated solution containing radioactive ATP and glucose, KCl, Mops-Tris, and EDTA, as well as 0.2 ml of another solution of nonradioactive ATP at various concentrations; final concentrations were 100 mM KCl, 50 mM Mops-Tris (final pH was 7.0, at 20 °C), 240 mM sucrose, 0.8 mM Mg2+, and 1.5 mM EDTA; in the various samples, [3H]glucose was present at an activity of 2 µCi/ml and a total concentration of 1 mM, whereas [gamma -32P]ATP was present at a constant activity of 0.4 µCi/ml but at various total concentrations, ranging from 10 µM to 3 mM. These 2-ml samples were loaded onto Centricon 10 devices, and after centrifugation 10-µl aliquots were taken out of the concentrate for double labeling counting (i.e. estimation of total [gamma -32P]ATP concentrations) and measurement of the protein concentrations. After taking into account blank experiments performed in the absence of any added protein, the protein-dependent increase in [gamma -32P]ATP concentration in the concentrate, for a given total ATP concentrations, was corrected for slight variations in protein concentration. On average, the concentration of protein rose from 0.16 to about 4.8 mg/ml in SR samples. In the experiments with proteinase K-treated SR, we estimated a similar 30-fold increase in peptide concentration. Since 90% of the 29/30 domains was recovered after the proteolysis and Centricon 100 recentrifugation steps, and since the initial SR protein concentration was 10-fold higher in the experiment with proteinase K-treated SR than in that with intact SR (2 mg/ml instead of 0.2 mg/ml), this resulted in a molar concentration of ATP-binding sites 9-fold higher for p29/30 fragments (triangles) than for intact SR ATPase (circles). The data were fitted to Michaelian binding (see "Experimental Procedures") with Kd = 34 µM, Etot = 15.3 µM (i.e. 3.2 nmol/mg protein), and alpha  = 0.02 for intact SR ATPase, and K'd = 680 µM, E'tot = 138 µM, and alpha ' = 0.06 for p29/30 fragments.

Retention by p29/30 Fragments of High Sensitivity to Trypsin and Reactivity with FITC-- After having demonstrated the ability of p29/30 fragments to bind nucleotides, we asked whether these fragments also retain two other properties characteristic of intact ATPase, i.e. strong susceptibility to trypsin of the Arg505-Ala506 peptidic bond, and high reactivity toward FITC of Lys515. The results of experiments designed to explore these aspects are shown in Fig. 5.


View larger version (85K):
[in this window]
[in a new window]
 
Fig. 5.   Sensitivity to trypsin of the Arg505-Ala506 bond in p29/30 fragments, and reactivity of Lys515 toward FITC in these fragments. In this experiment, the same medium was used both for proteolysis with proteinase K and/or trypsin and for labeling with FITC; it contained 0.3 M sucrose, 1 mM Mg2+, 10 µM Ca2+, and 10 mM Tricine-Tris at pH 8 and 20 °C. After samples were run on a SDS-PAGE/Tricine gel, the gel was examined immediately for fluorescence (panel B) and subsequently stained with Coomassie Blue (Coom. blue) (panel A). Lane 7, molecular mass markers (see panel A); the large spot in lane 7 of panel B corresponds to the tracking dye in the migration front. Lane 3, FITC-labeled SR vesicles. Labeling was partial and corresponded to 1 nmol FITC/mg of protein. Lanes 4-6, the same labeled vesicles (2 mg/ml) were submitted to proteolysis, either (i) for 2 min with 125 µg/ml trypsin (lane 4; in panel A, fragments A and B are apparent, as well as A1, A2 superimposed with trypsin (Tr), and the trypsin inhibitor (Tr Inh)), or (ii) for 30 min with 30 µg/ml proteinase K (lane 5, p29/30 peptides are indicated), or again (iii) with proteinase K first, followed by trypsin (lane 6). Lanes 1 and 2, a sample similar to the one for lane 5, but prepared from unlabeled SR vesicles, was centrifuged. The supernatant was then incubated with 2 µM FITC for 30 min and subsequently either (i) loaded onto lane 1, or (ii) submitted to trypsin treatment and then loaded onto lane 2, in the latter case, trypsin (Tr), trypsin inhibitor (Tr Inh), and three smaller peptides (designated as p17/18 and p12) are apparent (panel A). For fluorescence examination, the gel was deposited in a transparent box before acid fixation and Coomassie Blue staining and illuminated with UV light (302 nm). Fluorescence (panel B) was detected with a Kodak Wratten 55 green filter; the white dots are due to fluorescent defects in the plastic box. Panel C, the N termini of p12 peptides derived from trypsin cleavage of either nonlabeled or heavily FITC-labeled p29/30 fragments (see text) were sequenced. PTH-amino acids found after each cycle of Edman degradation were compared for the labeled "p12-FITC" peptide and the unlabeled "p12" peptide (the ratio is plotted). The second alanine residue was not determined quantitatively, hence the ×.

Panel A of this figure shows the result of Coomassie Blue staining of an SDS-PAGE/Tricine gel after separation of the fragments resulting from proteolysis of various samples with proteinase K, trypsin, or both. As a reference, intact Ca2+-ATPase and the associated Ca2+-binding proteins of SR vesicles are shown in lane 3. The well known bands A and B, as well as A1 and A2 (e.g. Ref. 31), resulting from SR treatment with trypsin are shown in lane 4, whereas treatment with proteinase K (lane 5) results in formation of a number of membranous fragments as well as of the soluble p29/30 fragments (see Ref. 15 and Fig. 1). Lane 6 in panel A shows that treatment with proteinase K, followed by treatment with trypsin, results in additional fragments. To permit identification of the fragments derived from p29/30, a separate proteinase K-treated sample was centrifuged, and although an aliquot of its supernatant, mainly containing p29/30 peptides, was deposited in lane 1, the rest of the supernatant was treated with trypsin and deposited in lane 2. Five bands are observed in lane 2, of which the two upper ones correspond to trypsin and the trypsin inhibitor; p29/30 fragments are absent: thus, these fragments are cleaved down to three fragments only, two of which (designated as p17 and p18) migrate close to each other, whereas the third one (designated as p12) migrates at a faster rate.

It should be noted that in the experiment illustrated by lanes 3-6, the SR vesicles had been labeled with FITC at Lys515 prior to proteolysis. Before Coomassie Blue staining, we were therefore in a position to examine which of the various peptides formed were fluorescent. Panel B in Fig. 5 shows that, as expected, fluorescence shows up in Ca2+-ATPase, the tryptic B fragment, and proteinase K fragments p81/83 and p29/30 (15); in addition, fluorescence shows up in the smallest (p12) of the three peptides resulting from p29/30 tryptic cleavage. This p12 peptide was blotted onto polyvinylidene difluoride (15) and subjected to N-terminal sequencing; it was found that its N-terminal sequence corresponds to cleavage of the Arg505-Ala506 peptidic bond (see also below). We conclude that, like in intact Ca2+-ATPase, the Arg505-Ala506 bond in p29/30 fragments resulting from proteinase K treatment is highly sensitive to trypsin.

Mass spectrometry (MALDI-TOF) experiments were fully consistent with this conclusion and extended its validity to the fragments resulting from Asp-N and elastase treatment of Ca2+-ATPase. Fig. 6 shows these results. A preliminary experiment was performed with a control protein, apomyoglobin; this allowed us both to calibrate the spectrometer response and to observe the presence of unexpected minor peaks (see asterisk in panel A) presumably due to formation of adducts between the polypeptide chain and the matrix with which it is initially co-crystallized. In the experiment illustrated in panel B, the peptides found in the supernatant of Asp-N-treated SR (Fig. 1) were further treated with trypsin (as in the case of proteinase K fragments, Fig. 5), and the smaller peptides generated were examined (see "Experimental Procedures"). Besides the minor adducts (asterisks), mass spectrometry reveals two major peaks (panel B), corresponding to the N-terminal part and the C-terminal part of the initial fragment. Because of its larger size, the peptide corresponding to the peak on the right is less efficiently desorbed by the laser beam than that corresponding to the peak on the left, but both masses can be estimated unambiguously. The measured m/z value of the larger peptide (17,227) corresponds closely to the theoretical value (17,225) expected for a peptide starting at Asp351 (the N-terminal residue of Asp-N fragments, as deduced from the sequencing experiments) and ending after Arg505. The Arg505-Ala506 bond is therefore highly reactive to trypsin in fragments resulting from Asp-N treatment of Ca2+-ATPase. The mass of the smaller peptide then allows us to determine the C-terminal residue of the fragment without ambiguity, in this case Arg615 (as indicated in Table I). The same experiment was repeated with fragments resulting from Ca2+-ATPase treatment with elastase (panel C); again two groups of peaks showed up, and the measured masses were consistent with the previously determined N-terminal residues and the existence of a unique tryptic cleavage site at the Arg505-Ala506 bond (see figure legend). The same conclusion was also true for proteinase K fragments (panel D). Thus, all fragments retain an exquisite sensitivity to trypsin of their Arg505-Ala506 peptidic bond.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 6.   MALDI-TOF mass spectrometry of proteolytic fragments, after further cleavage by trypsin. Panel A shows a control experiment with apomyoglobin, with adducts between the polypeptide and the matrix (sinapinic acid) showing up as minor peaks indicated by asterisks, both in this panel and in the other ones. For the experiments illustrated in panels B-D, the supernatant of SR treated with Asp-N (panel B), elastase (panel C), or proteinase K (panel D) (as for Fig. 1) was further treated with trypsin (4 µg/ml, 30 min at 20 °C). The resulting peptides were desalted (see "Experimental Procedures") and examined by MALDI-TOF mass spectrometry. The peptides corresponding to peaks in panel B are indicated in parentheses in the figure, together with their theoretical [M + H+] values. For the peaks in panels C and D, these peptides and the theoretical [M + H+] values are as follows: panel C, C-terminal half-peptides: 12,086 (Ala506-Cys614, 12,078 theoretical value), 11,542 (Ala506-Gly609, 11,533 theoretical value), 11,629 (Ala506-Ser610, 11,621 theoretical value), 11,126 (Ala506-Lys605, 11,117 theoretical value), panel C, N-terminal half-peptides: 17,321 (Ser350-Arg505, 17,312 theoretical value), 16,886 (Gly354-Arg505, 16,880 theoretical value); panel D, C-terminal half-peptides: 11,623 (Ala506-Ser610, 11,621 theoretical value), 11,480 (Ala506-Met608, 11,476 theoretical value), 11,117 (Ala506-Lys605, 11,117 theoretical value); panel D, N-terminal half-peptides: 16,619 (Thr357-Arg505, 16,609 theoretical value), 17,318 (Ser350-Arg505, 17,312 theoretical value), 16,300 (Gln360-Arg505, 16,293 theoretical value).

FITC is a covalent specific reagent for Lys515 in the Ca2+-ATPase cytoplasmic domain (32). To study the reactivity toward FITC of Lys515 in p29/30, we performed two kinds of experiments. The results of the first approach can be seen in lanes 1 and 2 in Fig. 5B. In the experiment illustrated by these lanes, the supernatant of proteinase K-treated Ca2+-ATPase was prepared from unlabeled SR vesicles, and p29/30 fragments were subsequently labeled by adding FITC directly to this supernatant, under less than stoichiometric conditions (to reduce unreacted FITC to a minimum); subsequently, as explained above, these fragments were treated with trypsin and processed for SDS-PAGE. Comparison of lanes 2 and 6 in Fig. 5B shows that FITC added to p29/30 only labels the p12 peptide and neither the p17 nor the p18 peptides, although the p12 peptide contains fewer lysine residues than the two other peptides (7 lysine residues compared with 12 or 13). Selectivity of labeling is thus demonstrated. In the second approach, the same protocol was used, but the unlabeled p29/30-containing supernatant was now either (i) reacted with an excess of FITC (16 µM) first, followed by elimination of unreacted FITC (by passing through a Pharmacia PD10 column) and subsequent treatment with trypsin, or (ii) treated with trypsin in the absence of any FITC labeling. In both cases, this was followed by SDS-PAGE separation of the resulting peptides, electrotransfer onto polyvinylidene difluoride membranes, and N-terminal sequencing of p12. In the peptide derived from the FITC-treated sample, we expected that sequencing would not be able to identify the FITC-modified residue. Indeed, the yield of the 10th residue (corresponding to Lys515) was much lower in the FITC-treated sample (designated as p12-FITC) than in the non-reacted one (designated as p12) (see panel C in Fig. 5). This confirms that selective labeling of Lys515 has occurred in the p29/30 fragment, as in intact Ca2+-ATPase, resulting in disappearance of at least close to 50% of Lys515 residues. The reason why the other half of the Lys515 residues appears not to have been modified was not investigated further. It is possible that labeling is less selective for p29/30 fragments than for ATPase; it is possible also that the labeling period in our experiments (30 min at pH 8 only) is simply not sufficient for 100% labeling of the proteolytic fragments, although it is sufficient for intact ATPase.

Hydrodynamic Properties of p29/30 Fragments, Secondary Structure, and Spectroscopic Characterization of p29/30 Fragments-- The hydrodynamic properties of p29/30 fragments were examined by gel filtration on a TSK G3000 SWXL column (33). As shown in Fig. 7, a sharp major peak showed up in the eluant, together with minor smaller peptides. On the basis of column calibration with water-soluble proteins, the position of the major peak corresponds to a Stokes radius of 24 Å. Since Rmin for a 29.5-kDa protein can be estimated to be 20.6 Å (using a partial specific volume of 0.745 cm3/g), this Stokes radius corresponds to a frictional ratio of 1.17. This frictional ratio is compatible with an almost perfectly globular shape of the p29/30 fragments, i.e. a compact structure, consistent with the resistance of the fragments to most proteolytic enzymes.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 7.   Gel filtration of p29/30 fragments. Here, p29/30 fragments were prepared by proteolysis with agarose-bonded proteinase K (Sigma P9290), as follows: 5 mg of washed agarose beads were suspended in 500 µl of buffer (100 mM Bis-Tris and 2.5 mM EGTA at pH 6), and SR was added to a final concentration of 1 mg/ml; after 2 h at 18 °C under gentle stirring, the reaction was stopped (0.5 mM PMSF), and low speed centrifugation on a table-top centrifuge was performed to remove the beads, followed by high speed centrifugation (Beckman rotor TLA-100, 90,000 rpm, 1 h at 4 °C); the supernatant was then concentrated on Centricon 10 (Amicon), and 40 µl at 2 mg/ml protein were finally loaded onto the column. These fragments were chromatographed (33) at 20 °C on a TSK G3000 SWXL column (0.78 × 30 cm, with a precolumn) equilibrated with 100 mM KCl, 0.1 mM Ca2+, and 10 mM Tes (pH 7.5), and eluted with the same buffer at a flow rate of 0.5 ml/min; p29/30 is seen eluting as a sharp peak between the void volume (V0) and the total volume (Vt) of the column, together with minor amounts of smaller peptides. The inset shows a calibration of the column, i.e. Stokes radius (Rs) as a function of the distribution coefficient KD (KD = (Ve - V0)/(Vt - V0)) for the following proteins (with Stokes radius in parentheses): ferritin (Ferr, 6.3 nm), bovine serum albumin (BSA, 3.5 nm), ovalbumin (Ova, 2.8 nm), beta -lactoglobulin (beta Lgb, 2.75 nm), chymotrypsinogen (CTG, 2.25 nm), and pancreatic ribonuclease (RNase, 1.75 nm).

The fact that p29/30 fragments have a well organized structure was also checked by circular dichroism (CD) measurements. As shown in panel A of Fig. 8, the supernatants of SR vesicles treated with proteinase K for 15 and 30 min (dashed and solid lines, respectively) have CD spectra whose shapes are closely similar and whose amplitudes only slightly differ, consistent with almost complete conversion of ATPase to p29/30 fragments after 30 min. After 120 min proteolysis (dashed-dotted line), the slightly more pronounced trough at 205-207 nm is indicative of further hydrolysis of p29/30 to small disorganized peptides (random coils exhibit strongly negative ellipticities below 200 nm); however, this trend is much more apparent after an additional 10 h proteolysis at 37 °C (dotted line). After analysis of the total amino acid contents of the supernatant resulting from 30-min proteolysis, the measured ellipticity was converted to molar ellipticity: for this 30-min supernatant, the result, expressed in degrees·cm2·dmol-1, is shown by the solid line in panel B of Fig. 8. Since such a supernatant sample in addition to p29/30 peptides contains the very small peptides derived from the 608/610-734/747 region (15), we also attempted to obtain purer p29/30 peptides by passing this supernatant over a Sephadex G25M column before measuring ellipticity and amino acid contents of the fraction eluted in the void volume; the result is shown by the dashed line in panel B, which, as expected, reveals a larger (negative) molar ellipticity at 222 nm (characteristic of alpha  helices) and a smaller relative contribution of the trough at 205-207 nm in the Sephadex eluate, compared with the initial supernatant. For comparison, the molar ellipticity of C12E8-solubilized deoxycholate-extracted ATPase is also shown in panel B as a dashed-dotted line.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 8.   CD spectra of soluble proteolytic fragments. For these experiments, proteolytic cleavage of Ca2+-ATPase was performed in a medium containing 4 mg/ml SR protein, 30 µg/ml proteinase K, 10 mM NaCl, and 10 mM Na2HPO4/NaH2PO4 at pH 7.5. For panel A experiments, proteolysis was stopped with PMSF after 15, 30, or 120 min at 20 °C (dashed line, solid line, and dashed-dotted line, respectively), samples were centrifuged, and supernatants, after 4-fold dilution in the same medium, were examined for their CD spectra in a cell of 0.2-mm optical path length. Problems due to too high absorbance were restricted to the 180-184-nm region (hatched box), and the base line was subtracted. We also prepared a sample which, after 120 min proteolysis at 20 °C, was centrifuged to remove membranous fragments but to which PMSF the proteinase K inhibitor was not added; this supernatant was incubated for an additional 10 h at 37 °C (dotted line), to produce extensive hydrolysis of p29/30 fragments (as tested by SDS-PAGE; data not shown). For panel B experiments, 0.9 ml of the supernatant after 30 min proteolysis was passed through a Sephadex G25M column (Pharmacia PD10) to separate larger peptides from the smaller peptides, and the larger peptides (p29/30) eluting in the void volume were pooled and diluted 2-fold for CD measurements (dashed line). The measured ellipticity was compared with that of two other samples, total supernatant, diluted four times (same sample as in panel A, solid line) and intact deoxycholate-extracted ATPase, solubilized in the presence of 4 mg/ml C12E8, the CD of which was measured at 0.2 mg of protein/ml. For all three samples illustrated in panel B, the total amino acid contents were also determined to make it possible to plot molar ellipticities.

All these spectra were analyzed to estimate, according to various methods, the percentage of the various secondary structures present in p29/30 peptides. Depending on the method, as made possible by the "Dichroprot" software, 28 (±5)% of amino acids were estimated to be involved in alpha -helices in the p29/30-containing Sephadex eluate (compared with 43 (±5)% in C12E8-solubilized ATPase). According to some of these methods, e.g. the "variable selection method" (34, 35), the proportion of amino acids involved in beta -structures (either parallel or anti-parallel) was higher for p29/30 fragments than for the entire ATPase, 20 (±3)% compared with 14 (±3)%, and beta -turns represented 19 and 15%, respectively (again ±3%). Thus, an unambiguous outcome of these measurements is the demonstration that a significant fraction of amino acids in p29/30 fragments are organized in defined secondary structures.

We finally performed a few experiments to characterize from a spectroscopic point of view the soluble p29/30 subdomain. We first focused on intrinsic fluorescence. After proteinase K treatment, the fluorescence spectrum of non-centrifuged samples is similar to that of control ATPase, although slightly less intense (not shown). As shown in panel A of Fig. 9, normalized excitation spectra reveal that the Trp shoulder at 290 nm is less prominent for the p29/30-containing supernatant of such samples (dotted line) than for the total samples (solid lines); in addition, the emission spectrum of the p29/30-containing supernatant is red-shifted by about 6 nm compared with the fluorescence of the total sample, which probably indicates that the environment for Trp552 in p29/30 peptides is more polar than, on average, the environment of the other 12 Trp residues of Ca2+-ATPase; the latter residues in native ATPase are thought to reside in or close to the ATPase transmembrane sector (2).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 9.   Spectroscopic characterization, in p29/30 fragments, of Trp fluorescence, FITC fluorescence, and energy transfer from Trp to FITC. Panel A, excitation (left) and emission (right) intrinsic fluorescence spectra. SR vesicles were treated for 45 min as for Fig. 2, and spectra for non-centrifuged samples (Tot) and supernatants (Sup) (solid and dotted lines, respectively) were examined after 10-fold dilution (to 100 µg/ml protein for non-centrifuged samples) into a medium containing 100 mM KCl, 5 mM Mg2+, and 50 mM Mops-NaOH at pH 7 and 20 °C. lambda ex was 290 nm for emission spectra, and lambda em was 330 nm for excitation spectra (hence the Rayleigh peaks). Spectra were normalized to the same maximal level. Panel B, excitation spectra for FITC (lambda em = 520 nm, hence the Rayleigh peaks), after 50-fold dilution into the same medium as for panel A of samples in which FITC was either (i) bound to intact FITC-labeled Ca2+-ATPase (solid line), or (ii) bound to p29/30 fragments (dashed line) in the supernatant of FITC-labeled vesicles treated for 30 min like in panel A experiment, or (iii) bound to the small peptides resulting from extensive proteolysis of FITC-labeled SR vesicles after an additional 6 h at 37 °C in the presence of 0.6 mg/ml proteinase K (dashed-dotted line), or (iv) free in buffer, at a similar concentration (dotted line; the excitation spectrum of this sample is close to that of the previous one, but its Rayleigh peak is smaller, as expected). Inset, Stern-Volmer plot of FITC quenching by KI, with FITC either bound to Ca2+-ATPase (circles), bound to the supernatant peptides after 15 or 45 min proteolysis (inverted triangles and triangles, respectively), or free in solution (squares). Panel C, emission spectra revealing fluorescence transfer from Trp to bound FITC in p29/30 fragments. Unlabeled SR vesicles (2 mg/ml) were treated for 30 min with proteinase K as for Figs. 3 and 4 and centrifuged, and the supernatant was incubated for 30 min with or without 16 µM FITC. Samples were diluted 20-fold in a pH 7 medium as for panels A and B. Emission spectra (with lambda ex = 290 nm) were recorded for (i) unlabeled supernatant (solid line), (ii) free FITC (dashed line), and (iii) FITC-labeled supernatant (dotted line). All spectra are corrected for Raman scattering.

We also examined the characteristics of the fluorescence of FITC, either free or bound to p29/30 fragments or intact Ca2+-ATPase. Panel B in Fig. 9 shows that the excitation spectrum of FITC bound to intact Ca2+-ATPase (solid line) is red-shifted by almost 10 nm with respect to that of free FITC (dotted line). This fact, together with the lower pKa observed for ATPase-bound FITC compared with free FITC (pKa of 5.8 instead of 6.4, see Ref. 36), indicates that bound FITC experiences an environment different from that for free FITC. Panel B also shows that the excitation spectrum of bound FITC after proteinase K treatment is an intermediate one, in both the non-centrifuged samples (data not shown) and the p29/30-containing supernatants (in Fig. 9B, the dashed line corresponds to a supernatant obtained after 30 min proteolysis). Complete disappearance of p29/30 fragments after extensive proteolysis results in an excitation spectrum similar to that of free FITC (dashed-dotted line). These results suggest the environment of bound FITC in p29/30 fragments produced by proteinase K treatment is somewhat different from its environment in intact Ca2+-ATPase but is not changed to the extent that it would become completely exposed to the aqueous medium. This conclusion is strengthened by experiments in which solvent accessibility of FITC is examined with the quenching agent iodide (see inset to Fig. 9B); as previously found (36), FITC accessibility to iodide is higher for free FITC than for FITC bound to Ca2+-ATPase (slopes for Stern-Volmer plots are 6.5 M-1 and 2.7 M-1, respectively), suggesting restricted accessibility to FITC, a suggestion supported by immunoreactivity data (37). In p29/30 fragments, this accessibility has an intermediate value, close to that of FITC in intact Ca2+-ATPase (slopes for Stern-Volmer plots are 3.1 or 3.9 M-1 for supernatants after 15 or 45 min proteolysis, respectively; in the latter case, degradation of p29/30 fragments to much smaller peptides contributes to the larger slope). Thus, the environment of FITC in p29/30 fragments is still significantly protected from the aqueous solvent.

Finally, panel C in Fig. 9 shows that Trp552 and bound FITC are close enough in p29/30 fragments to allow fluorescence transfer from the indole moiety to the fluorescein moiety to occur. Since nothing is known about the relative orientations of these two fluorophores, we cannot, however, derive from the data a distance between these two moieties. For random relative orientation of the indole and fluorescein moieties, the modest transfer observed in Fig. 9C would imply a distance between the two fluorescent moieties larger than 25 or 30 Å, the Förster radius R0. Alternatively, the distance could be smaller if the two fluorescent moieties are positioned relative to each other in a relatively rigid way unfavorable for energy transfer.

Demonstration of Metal-binding Sites in p29/30-- When the measurements of either TNP-ATP fluorescence or Trp fluorescence illustrated in Figs. 2 and 3 were repeated with p29/30 fragments in the presence of Mg2+ (5 mM), we found that the fluorescence responses due to nucleotide binding to the fragments were reduced, presumably because of a decreased binding affinity (data not shown). The same counterproductive effect of Mg2+ on TNP-ATP binding was previously noted by Moutin et al. (14) with the heterologously expressed isolated large cytoplasmic loop. Nevertheless, in our intrinsic fluorescence measurements, as those in Ref. 14, there was no direct evidence for binding of Mg2+ per se to the soluble p29/30 fragments; two additions of Mg2+, 5 mM each time, performed in the absence of nucleotide, had no effect on the intrinsic fluorescence level of p29/30 fragments (data not shown).

In contrast, by using lanthanide ions, we obtained direct evidence for metal binding to p29/30 in the absence of nucleotides. This was investigated by using Nd3+ ions and SR vesicles previously labeled with FITC at Lys515. Nd3+ has previously been shown to quench the fluorescence of bound FITC by up to 40%, even at high ionic strength (39, 40), probably because of efficient Förster transfer from the fluorescein moiety of bound FITC to an Nd3+ ion bound very close to it on the ATPase, at a distance of about 1 nm. The specificity of this interaction is suggested by the fact that Mg2+ competes with Nd3+, and it has been argued that the Nd3+ ion responsible for FITC quenching may be bound to a metal-binding subsite normally occupied by Mg2+ and located (because of the short FITC-Nd3+ distance) in the ATPase active cleft (39). Thus, in the experiment illustrated in Fig. 10, we examined quenching by Nd3+ of FITC fluorescence in FITC-labeled p29/30 fragments. These fragments were prepared by first labeling SR vesicles with FITC (17), followed by treatment with proteinase K and centrifugation. Increasing concentrations of Nd3+ were added either to non-centrifuged samples (closed symbols in Fig. 10) or to their supernatants (open symbols in Fig. 10).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 10.   Binding of Nd3+ ions to FITC-labeled Ca2+-ATPase. FITC-labeled SR vesicles were treated with proteinase K for various periods under conditions identical to those described in Fig. 2; aliquots were centrifuged, and lanthanide-induced quenching of FITC fluorescence in the various samples was measured. Closed symbols represent total samples and open symbols represent supernatants. Circles refer to control experiments with intact SR-FITC; for the other experiments, proteolysis duration was 30 (open diamonds) or 45 min (closed and open triangles). Aliquots of the treated samples were diluted 50-fold in a medium containing 5 mM Mg2+, 0.1 mM Ca2+, 500 mM KCl, and 40 mM Mops-NaOH at pH 7 and 20 °C (this high ionic strength is designed to reduce nonspecific interactions with the trivalent Nd3+ ion, see Ref. 39). FITC fluorescence was examined with lambda ex = 495 nm (bw = 2 nm) and lambda em = 520 nm (bw = 5 nm). The fluorescence data are normalized and plotted as percent of the initial fluorescence level in the absence of lanthanide. Additional experiments include quenching by Nd3+ of FITC free in solution (open squares) and quenching by Nd3+ of covalently bound FITC after an additional 6 h of proteolysis in the presence of 0.6 mg/ml proteinase K at 37 °C (closed squares); the dotted line corresponds to an experiment performed with La3+ instead of Nd3+. For millimolar Nd3+ concentrations, inner filter effects caused by Nd3+ absorbance begin to be detectable (not shown).

When examined at excitation and emission wavelengths commonly used for free FITC (495 and 520 nm, respectively), total FITC fluorescence slightly varies during proteolysis (data not shown), presumably in part because of the small spectral change of bound FITC after proteolysis documented in Fig. 9B. When treated samples are centrifuged, the proportion of FITC fluorescence recovered in the supernatant increases with the proteolysis period, up to almost 100% (data not shown), in agreement with almost complete degradation of the region around Lys515 to soluble fragments. As proteolysis proceeds, the well known sensitivity of covalently bound FITC to high affinity Ca2+ binding to Ca2+-ATPase (41) progressively vanishes, again as expected (data not shown). Nevertheless, after 30 or 45 min proteolysis, quenching by Nd3+ is retained to a significant extent for proteolyzed samples as well as for their supernatants. Analysis of such quenching curves is best performed when the data are normalized, and residual fluorescence is expressed as percent of the initial fluorescence in the absence of Nd3+, as shown in Fig. 10. For 30-300 µM Nd3+, quenching by Nd3+ of FITC fluorescence in p29/30 fragments (triangles and diamonds) is definitely observed, although to a lesser extent than in Ca2+-ATPase (closed circles). Open and closed squares are two control experiments designed to confirm the insensitivity to Nd3+ of (i) FITC in solution (open squares) and (ii) FITC bound to the ATPase peptides resulting from extensive proteolysis (closed squares; in this case, proteolysis was performed as in the experiment corresponding to the dashed-dotted line in Fig. 9B). The dotted line illustrates a different control experiment showing that, as expected because of the lack of absorbance properties, La3+ does not quench fluorescence of FITC bound to intact Ca2+-ATPase. These data demonstrate that soluble p29/30 fragments retain some residual ability (although with reduced affinity, as in the case of nucleotide binding) to bind lanthanide ions relatively close to FITC bound at Lys515.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

In this report, we show that by using various proteolytic enzymes (Fig. 1), it is possible to prepare fragments of Ca2+-ATPase closely related to each other and all originating from the cytosolic portion of this membranous enzyme (Table I). According to hydrodynamic and circular dichroism analysis, these "p29/30" fragments have a compact globular shape with a relatively high content of secondary (alpha /beta ) structure (Figs. 7 and 8). They have a significant affinity toward nucleotides (Figs. 2-4) and also retain reactivity toward trypsin and FITC, like intact Ca2+-ATPase, and at the same sites (Figs. 5 and 6). All this suggests that these proteolytic fragments, which contain a major fraction of the ATPase cytosolic head, are released without loss of basic structural features from a region which, in the native tertiary structure, constitutes an autonomous structural domain.

The reasons why the properties of p29/30 fragments have not been recognized earlier are probably related to the fact that most previous proteolytic investigations on Ca2+-ATPase have been performed with trypsin. Studies with this enzyme have never resulted in production of fragments comparable to those described in the present work because trypsin has an extraordinary potency for cleavage of Ca2+-ATPase in the middle of the molecule, at Arg505-Ala506. We found no evidence for a particular sensitivity of the Arg505-Ala506 peptidic bond to proteases other than trypsin; thus, the high sensitivity to trypsin of this bond is probably due to a particular conformation of the Arg505-Ala506 peptidic bond, favorable for trypsinolysis, rather than to a strategic location of this bond at the boundary between two distinct domains of Ca2+-ATPase. It is remarkable that proteolysis fragments similar to our p29/30 fragments have in fact been already described for Na+,K+-ATPase and H+,K+-ATPase, after treatment with either trypsin (42) or other proteases (43-46).

Our extensive peptide sequencing and mass spectrometry data allow us to unambiguously conclude that p29/30 fragments start close to the phosphorylation domain, around residue Asp351, and end in the 605-615 region, well in advance of the conserved region starting around residue 670 (the so-called "hinge" region). N-terminal cleavage sites are consistent with a rather superficial localization of the phosphorylatable Asp351 residue, to which phosphorylating substrates must of course have access, in the region delimited by the CSD351KTGTLT motif. However, p29/30 fragments are probably not primary cleavage products, and the possibility therefore remains that accessibility to proteolytic attack is somewhat modified by previous cuts in the N-terminal and C-terminal regions of the ATPase (15). Concerning the C-terminal end in the 605-615 region, a region that has not been given much attention up to now, it is of interest that it is flanked by two conserved motifs, present in most eucaryotic P-type ATPases, D601PPR and MIT625GD. According to the Rost and Sander algorithm (47), the 608-616 region is surprisingly predicted to be alpha -helical and thus should be resistant to proteolytic enzymes; in contrast, the vulnerability of this region to proteolytic cleavage could indicate that this region forms a loop connecting p29/30 to the rest of the ATPase. It is worth noting also that according to the prediction in Ref. 2, 118-120 residues in the sequence corresponding to the isolated p29/30 fragments should be alpha -helical, i.e. more than 45%, whereas our CD measurements suggested a significantly smaller (about 28%) fraction of alpha -helical residues in these fragments.

Irrespective of the detailed conformation and location of the N-terminal and C-terminal boundaries of p29/30 fragments, it is clear from the present results that these fragments form a rather compact domain and that this domain is able to bind nucleotides with an affinity which is quite respectable but reduced compared with that of intact ATPase (Figs. 2-4). It is certainly not a surprise that a fragment lacking several highly conserved and functionally critical regions of the ATPase (including residues that obviously interact with the ATP-binding pocket like Arg678 and Lys684, see Ref. 12 for review) has a reduced affinity for its substrates. The important fact is the ability of p29/30 fragments to bind these ligands at all. Moutin et al. (14) previously concluded that the nucleotide-binding site was at least partially preserved in the ATPase peptide Lys329-Phe740 (prepared by heterologous expression in Escherichia coli), which corresponds to the entire "large cytosolic loop" of Ca2+-ATPase; our results show that the same conclusion is valid for our smaller p29/30 fragments, which only comprise Thr357/Ser350-Ser610/Met608 peptides. The observation that the presence of Mg2+ does not favor ATP or ADP binding to p29/30 fragments is of interest. It is known that in intact Ca2+-ATPase, an enhancing effect of Mg2+ on the affinity of nucleotide binding is only observed for ATP but not for ADP (30); thus, such an enhancing effect of Mg2+ is not characteristic of the portion of the site that recognizes the adenine moiety. In Na+,K+-ATPase also, high affinity binding of ATP is not dependent on Mg2+. In addition, there is in Na+,K+-ATPase evidence for electrostatic interaction between the gamma -phosphate of ATP and the phosphorylatable residue (48, 49); corresponding interactions will obviously be affected by proteolysis in our p30 or p29 peptides (starting at Ser350 and Thr357, respectively) since the region around the phosphorylation site (Asp351) is either absent (p29) or presumably poorly structured (p30). Thus, the fact that MgATP does not appear to bind to p29/30 fragments (nor to bind to the entire large cytosolic loop, see Ref. 14) with an affinity higher than that of Mg2+-free ATP should not be taken as an objection against the nucleotide binding ability of p29/30 fragments, which we think is demonstrated here unambiguously. It is also worth pointing out that the nucleotide binding abilities of the proteolysis-derived p29/30 fragments (this work) and of the heterologously expressed large cytosolic loop (14) are of the same order of magnitude, despite the fact that the former fragments are 35-40% shorter than the latter (residues 350/357-608/610 compared with residues 329-740).

Although P-type ATPases lack the classical glycine-rich Walker sequence motifs found in water-soluble kinases (50), it has previously been suggested that like these kinases, the large cytosolic loop of Ca2+-ATPase comprises two distinct domains, a phosphorylation domain and an ATP-binding domain (2). Mainly based on the existence of a tryptic split at Arg505-Ala506, between the phosphorylation site (Asp351) and the ATP-protected FITC-binding site (Lys515), the Arg505-Ala506 bond was originally thought to be involved in the separation between phosphorylation and ATP-binding subdomains. Subsequent work, however, indicated that residues located N-terminally of Arg505 also play an important role in nucleotide binding (e.g. Ref. 51). Based on the present data, we speculate that in Ca2+-ATPase and probably also in other P-type ATPases, the ATP-binding region mainly consists of the p29/30 domain, with the phosphorylation site located at the N-terminal border of this domain. In this view, interaction with the rest of the molecule of the rather compact p29/30 domain would be made possible by flexibility of the regions connecting this domain to the rest of the molecule; on the one hand, the strategic location of the phosphorylation site at the N-terminal boundary of the domain would be consistent with the demand, from an energy-transducing enzyme, of conformational flexibility at the active site; on the other hand, the 605-615 region at the C-terminal boundary of the domain might constitute the real hinge with conformational flexibility. In this view, the conserved region starting around residue 670 (and whose previous description as a hinge was probably misleading)4 would be part of a second lobe, perhaps not strictly necessary for nucleotide binding (see Ref. 52) but whose precise positioning could set the stage for a nucleophilic attack on the gamma -phosphate of ATP and its transfer to the phosphorylatable Asp351 residue; note that binding of Ca2+ to the ATPase transport sites changes the precise positioning, with respect to the nucleotide-binding site, of Lys684 in this putative second lobe (Refs. 53 and 54; see Ref. 12 for review).

With respect to the above considerations it should be pointed out that it is not possible to completely exclude the possibility (as considered, for instance, in Ref. 45) that in intact ATPase the ATP-binding site could consist of a groove formed between the p29/30 subdomain and the rest of the molecule (the latter would then again presumably include the conserved region starting around residue 670, see review in Ref. 12). In this case, however, the affinity for ATP binding on one side of an isolated p29/30 domain would probably exhibit a reduction of much more than 1 order of magnitude compared with intact ATPase, which was not the case (see Fig. 4). In addition, assuming that the FITC planar chromophore is located at the same place as the nucleotide base in intact ATPase, it would be difficult to understand why FITC bound to p29/30 fragments remains significantly shielded from the aqueous environment (Fig. 9B). Thus, a more likely hypothesis might be that a cavity in the p29/30 domain provides most of the ligands for binding the adenine moiety of nucleotides. The answer to the question of the exact nature of the ATP-binding site will hopefully be provided by x-ray crystallography analysis of this domain with or without ATP bound to it.

In addition to nucleotides, we have shown here that p29/30 fragments are able to bind Nd3+ ions (Fig. 10); this observation deserves special comment. Although lanthanide binding to the ATPase Ca2+ transport sites has sometimes been advocated in the past, it has been demonstrated that these trivalent ions have an even higher affinity for other sites in the protein (21, 55-57), and the present study shows that some of these sites are located in the region of the ATPase cytosolic domain corresponding to p29/30. Whether these sites have any functional relevance is the next question. Based on the idea that the fluorescein moiety of FITC bound to Lys515 in intact ATPase occupies the nucleotide-binding cleft (32, 58), Highsmith (39) suggested that the large quenching effect exerted by Nd3+ (in competition with Mg2+) on FITC fluorescence was due to Nd3+ binding at a metal subsite in the catalytic active cleft of Ca2+-ATPase normally occupied by Mg2+. From other functional studies we know that replacement of Mg2+ by other metal ions (presumably in the catalytic cleft) can indeed occur, with the result that in the presence of lanthanide ions the ATPase is severely inhibited (e.g. Refs. 59-61). Along this line, the observed quenching by Nd3+ of FITC fluorescence in p29/30 fragments might suggest that p29/30 fragments provide some of the liganding groups for binding of catalytically active Mg2+. In Na+,K+-ATPase, a role of Asp586 (in the DPPR motif of the homologous domain) in coordinating the Mg2+ ion required for ATPase activity was also recently proposed (62-63). Note, however, that residues much further away toward the C-terminal end of the Ca2+-ATPase large cytosolic loop have also been proposed as Mg2+-binding sites (e.g. Refs. 52 and 64), and further studies are needed to clarify this issue. As a completely different and somewhat less attractive possibility, lanthanide ions might bind to p29/30 fragments at sites that are not relevant for ATPase activity. Nevertheless, even if this were the case, the present demonstration of lanthanide binding to p29/30 fragments could be useful for future phasing of x-ray diffraction diagrams. Before crystallization of p29/30-like domains, however, we have to prepare samples with a high purity. Our hydrodynamic and spectroscopic characterization of freshly prepared proteolysis-derived fragments (Figs. 7-9) will then help check that purification procedures have not subsequently led to irreversible changes in conformation for the purified peptide(s).

    ACKNOWLEDGEMENTS

We thank Françoise Baleux (Institut Pasteur, Paris) for total amino acid analysis; Bernard Lagoutte (CEA, Saclay) for kindly performing a few N-terminal sequencing experiments; Béatrice de Foresta for critically reading our manuscript; Jean-Pierre Le Caer (ESPCI and CNRS, Paris) for permanent assistance with the mass spectrometry experiments; and François Penin and Gilbert Deléage (IBCP, Lyon) for their expert help with deconvolution of CD spectra and the Dichroprot software they made accessible to us.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence may be addressed. Tel.: 33-1-6908-3731; Fax: 33-1-6908-8139.

Both authors contributed equally to this work.

Dagger Dagger Present address: Laboratoire de Physico- et Toxico-Chimie, Des Systemes Naturels, Universite Bordeaux I, 351, Cours de la Liberation, 33405 Talence Cedex, France

§§ Present address: Laboratoire de Pharmacologie et Neurochimie, Faculté de Pharmacie, Université Claude Bernard-Lyon I, 8 avenue Rockfeller, 69373 Lyon Cedex 08.

1 The abbreviations used are: SR, sarcoplasmic reticulum; Asp-N, endoproteinase Asp-N; PMSF, phenylmethylsulfonyl fluoride; FITC, fluorescein 5'-isothiocyanate; Mops, 4-morpholinepropanesulfonic acid; Tes, N-tris[hydroxymethyl]methyl-2-aminoethanesulfonic acid; Bis-Tris, bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane; Tricine, N-tris(hydroxymethyl)methylglycine; PAGE, polyacrylamide gel electrophoresis; MALDI-TOF, matrix-assisted laser desorption ionization-time of flight; ; C12E8, octaethylene glycol monododecyl ether; TNP-nucleotides, 2',3'-O-(2,4,6-trinitrophenyl)nucleotides; lambda ex, excitation wavelength; lambda em, emission wavelength; bw, spectral bandwidth; inner filter effect, fluorescence reduction due to absorbance by the sample of excitation or emission wavelength.

2 Available on-line at the following E-mail address: deleag{at}ibcp.fr

4 Note also that in soluble kinases, the real hinge is located between the phosphorylation site and the nucleotide-binding site, not after both of them, as seemingly implied by the current description of Ca2+-ATPase where the so-called hinge region is rather far away toward the C-terminal end.

3 T. Menguy, S. Chenevois, F. Guillain, M. le Maire, P. Falson, and P. Champeil, manuscript in preparation.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. MacLennan, D. H., Brandl, C. J., Korczak, B., and Green, N. M. (1985) Nature 316, 696-700[Medline] [Order article via Infotrieve]
  2. Brandl, C. J., Green, N. M., Korczak, B., and Mac Lennan, D. H. (1986) Cell 44, 597-607[Medline] [Order article via Infotrieve]
  3. Toyoshima, C., Sasabe, H., and Stokes, D. (1993) Nature 362, 469-471[CrossRef]
  4. Dux, L., Taylor, K. A., Ting-Beall, H. P., Martonosi, A. (1985) J. Biol. Chem. 260, 11730-11743[Abstract/Free Full Text]
  5. Taylor, K. A., Dux, L., and Martonosi, A. (1986) J. Mol. Biol. 187, 417-427[Medline] [Order article via Infotrieve]
  6. Stokes, D. L., and Green, N. M. (1990) Biophys. J. 57, 1-14[Abstract]
  7. Lee, A. G. (1996) in Biomembranes (Lee, A. G., ed), Vol. 5, pp. 1-42, Jai Press Inc., Greenwich, CT
  8. Møller, J. V., Juul, B., and le Maire, M. (1996) Biochim. Biophys. Acta 1286, 1-51[Medline] [Order article via Infotrieve]
  9. Mintz, E., and Guillain, F. (1997) Biochim. Biophys. Acta 1318, 52-70[Medline] [Order article via Infotrieve]
  10. Yonekura, K., Stokes, D., Sasabe, H., and Toyoshima, C. (1997) Biophys. J. 72, 997-1005[Abstract]
  11. Taylor, W. R., and Green, N. M. (1989) Eur. J. Biochem. 179, 241-248[Abstract]
  12. McIntosh, D. B. (1998) Adv. Mol. Cell Biol. 23, 33-99
  13. Capieaux, E., Rapin, C., Thines, D., Dupont, Y., and Goffeau, A. (1993) J. Biol. Chem. 268, 21895-21900[Abstract/Free Full Text]
  14. Moutin, M. J., Cuillel, M., Rapin, C., Miras, R., Anger, M., Lompré, A. M., Dupont, Y. (1994) J. Biol. Chem. 269, 11147-11154[Abstract/Free Full Text]
  15. Juul, B., Turc, H., Durand, M. L., Gomez de Gracia, A., Denoroy, L., Møller, J. V., Champeil, P., le Maire, M. (1995) J. Biol. Chem. 270, 20123-20134[Abstract/Free Full Text]
  16. Champeil, P., Guillain, F., Vénien, C., and Gingold, M. P. (1985) Biochemistry 24, 69-81[Medline] [Order article via Infotrieve]
  17. Champeil, P., Riollet, S., Orlowski, S., Guillain, F., Seebregts, C. J., McIntosh, D. B. (1988) J. Biol. Chem. 263, 12288-12294[Abstract/Free Full Text]
  18. Meissner, G., Conner, G. E., and Fleischer, S. (1973) Biochim. Biophys. Acta 298, 246-269[Medline] [Order article via Infotrieve]
  19. le Maire, M., Lund, S., Viel, A., Champeil, P., and Møller, J. V. (1990) J. Biol. Chem. 265, 1111-1123[Abstract/Free Full Text]
  20. Soulié, S., Møller, J. V., Falson, P., and le Maire, M. (1996) Anal. Biochem. 236, 363-364[CrossRef][Medline] [Order article via Infotrieve]
  21. Henao, F., Orlowski, S., Merah, Z., and Champeil, P. (1992) J. Biol. Chem. 267, 10302-10312[Abstract/Free Full Text]
  22. de Foresta, B., Champeil, P., and le Maire, M. (1990) Eur. J. Biochem. 194, 383-388[Abstract]
  23. Karas, M., Bahr, U., Ingendoh, A., Nordhoff, E., Stahl, B., Strupat, K., and Hillenkamp, F. (1990) Anal. Chim. Acta 241, 175-185[CrossRef]
  24. Rusconi, F., Potier, M. C., Le Caer, J. P., Schmitter, J. M., Rossier, J. (1997) Biochemistry 36, 11021-11026[CrossRef][Medline] [Order article via Infotrieve]
  25. Dupont, Y., Chapron, Y., and Pougeois, R. (1982) Biochem. Biophys. Res. Commun. 106, 1272-1279[Medline] [Order article via Infotrieve]
  26. Watanabe, T., and Inesi, G. (1982) J. Biol. Chem. 257, 11510-11516[Abstract/Free Full Text]
  27. Nakamoto, R., and Inesi, G. (1984) J. Biol. Chem. 259, 2961-2970[Abstract/Free Full Text]
  28. Dupont, Y. (1976) Biochem. Biophys. Res. Commun. 71, 544-550[Medline] [Order article via Infotrieve]
  29. Green, N. M. (1989) Nature 339, 424-425[Medline] [Order article via Infotrieve]
  30. Lacapère, J. J., Bennett, N., Dupont, Y., and Guillain, F. (1990) J. Biol. Chem. 265, 348-353[Abstract/Free Full Text]
  31. Török, K., Trinnaman, B. J., and Green, N. M. (1988) Eur. J. Biochem. 173, 361-367[Abstract]
  32. Mitchinson, C., Wilderspin, A. F., Trinniman, B. J., Green, N. M. (1982) FEBS Lett. 146, 87-92[CrossRef][Medline] [Order article via Infotrieve]
  33. le Maire, M., Ghazi, A., and Møller, J. V. (1996) in Strategies in Size Exclusion Chromatography (Potschka, M., and Dubin, P., eds), pp. 36-51, ACS Symposium Series No. 635, Washington, D.C.
  34. Manavalan, P., and Johnson, W. C. (1987) Anal. Biochem. 167, 76-85[Medline] [Order article via Infotrieve]
  35. Johnson, W. C. (1990) Proteins 7, 205-214[Medline] [Order article via Infotrieve]
  36. Highsmith, S. (1986) Biochemistry 25, 1049-1054[Medline] [Order article via Infotrieve]
  37. Mata, A. M., Lee, A. G., and East, J. M. (1989) FEBS Lett. 253, 273-275[CrossRef][Medline] [Order article via Infotrieve]
  38. Deleted in proof
  39. Highsmith, S. (1984) Biochem. Biophys. Res. Commun. 124, 183-189[Medline] [Order article via Infotrieve]
  40. Ivkova, M. N., Pletnev, V. V., Vinokurov, M. G., Pechatnikov, V. A., Ivkov, V. G., Jona, I., Fölöp, J., Köver, A. (1992) Biochim. Biophys. Acta 1118, 231-238[Medline] [Order article via Infotrieve]
  41. Pick, U., and Karlish, S. J. (1980) Biochim. Biophys. Acta 626, 255-561[Medline] [Order article via Infotrieve]
  42. Tai, M. M., Im, W. B., Davis, J. P., Blakeman, D. P., Zurcher-Neely, H. A., Heinrikson, R. L. (1989) Biochemistry 28, 3183-3187[Medline] [Order article via Infotrieve]
  43. Saccomani, G., and Mukidjam, E. (1987) Biochim. Biophys. Acta 912, 63-73[Medline] [Order article via Infotrieve]
  44. Van Uem, T. J. F., Swarts, H. G. P., De Pont, J. J. H. H. M. (1991) Biochem. J. 280, 243-248[Medline] [Order article via Infotrieve]
  45. Tran, C. M., Huston, E. E., and Farley, R. A. (1994) J. Biol. Chem. 269, 6558-6565[Abstract/Free Full Text]
  46. Klaassen, C. H. W., and De Pont, J. J. H. H. M. (1994) Cell. Physiol. Biochem. 4, 115-134
  47. Rost, B., and Sander, C. (1993) J. Mol. Biol. 232, 584-599[CrossRef][Medline] [Order article via Infotrieve]
  48. Pedersen, P. A., Rasmussen, J. H., and Jørgensen, P. L. (1996) J. Biol. Chem. 271, 2514-2522[Abstract/Free Full Text]
  49. Nørby, J. G., and Esman, M. (1997) J. Gen. Physiol. 109, 555-570[Abstract/Free Full Text]
  50. Abrahams, J. P., Leslie, A. G., Lutter, R., and Walker, J. E. (1994) Nature 370, 621-628[CrossRef][Medline] [Order article via Infotrieve]
  51. McIntosh, D. B., Wooley, D. G., Vilsen, B., and Andersen, J. P. (1996) J. Biol. Chem. 271, 25778-25789[Abstract/Free Full Text]
  52. Vilsen, B., Andersen, J. P., and MacLennan, D. H. (1991) J. Biol. Chem. 266, 16157-16164[Abstract/Free Full Text]
  53. Yamamoto, H., Tagaya, M., Fukui, T., and Kawakita, M. (1988) J. Biochem. (Tokyo) 103, 452-457[Abstract]
  54. Yamamoto, H., Imamura, Y., Tagaya, M., Fukui, T., and Kawakita, M. (1989) J. Biochem. (Tokyo) 106, 1121-1125[Abstract]
  55. Sprowl, C. D., and Thomas, D. D. (1989) Biophys. J. 55, 16 (abstr.)
  56. Imamura, Y., and Kawakita, M. (1991) J. Biochem. (Tokyo) 110, 214-219[Abstract]
  57. Ogurusu, T., Wakabayashi, S., and Shigekawa, M. (1991) Biochemistry 30, 9966-9973[Medline] [Order article via Infotrieve]
  58. Pick, U., and Karlish, S. J. (1982) J. Biol. Chem. 257, 6120-6126[Free Full Text]
  59. Shigekawa, M., Wakabayashi, S., and Nakamura, H. (1983) J. Biol. Chem. 258, 14157-14161[Abstract/Free Full Text]
  60. Wakabayashi, S., and Shigekawa, M. (1987) J. Biol. Chem. 262, 11524-11531[Abstract/Free Full Text]
  61. Fujimori, T., and Jencks, W. P. (1990) J. Biol. Chem. 265, 16262-16270[Abstract/Free Full Text]
  62. Farley, R. A., Heart, E., Kabalin, M., Putnam, D., Wang, K., Kasho, V. N., Faller, L. D. (1997) Biochemistry 36, 941-951[CrossRef][Medline] [Order article via Infotrieve]
  63. Kasho, V. N., Stengelin, M., Smirnova, I. N., Faller, L. D. (1997) Biochemistry 36, 8045-8052[CrossRef][Medline] [Order article via Infotrieve]
  64. Girardet, J. L., Bally, I., Arlaud, G., and Dupont, Y. (1993) Eur. J. Biochem. 217, 225-231[Abstract]
  65. Hannaert-Merah, Z., Coquil, J. F., Combettes, L., Claret, M., Mauger, J. P., Champeil, P. (1994) J. Biol. Chem. 269, 29642-29649[Abstract/Free Full Text]
  66. Swillens, S., Waelbroeck, M., and Champeil, P. (1995) Trends Biochem. Sci. 16, 151-155[CrossRef]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.